Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Merck
Express Scripts
AstraZeneca
Colorcon

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc. (D. Del. 2009)

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Research Foundation of State University of New York v. Mylan Pharmaceuticals Inc. (D. Del. 2009)

Date Filed Document No. Description Snippet Link To Document
2010-05-12 134 quot;), 5,789,395 ("the '395 patent"), and 5,919,775 ("the '775 patent"). (…U.S. Patent Nos. 7,232,572 ("the '572 patent"), 7,211,267 ("the '267 patent"…both Ashley patents. b. The Amin Patents The Amin '395 patent, entitled…395 patent, claim 1; Amin '775 patent, claim I; Ashley' 572 patent, claim…expiration of the patents-in-suit. Plaintiffs subsequently brought this ANDA patent infringement action External link to document
2011-08-26 149 The "Amin Patents" are U.S. Patent No. 5,789,395 ("the '395 patent") (PTX 3) …the '267 patent, the '572 patent, the '395 patent, and the '775 patent. (SUF ~ 61) …#39;304 patent or the '819 patent renders the Chang Patent obvious. The '304 patent describes… IThere are five patents-in-suit. The "Ashley Patents" are U.S. Patent No. 7,211,267 ("…the '267 patent") (PTX 1) and U.S. Patent No. 7,232,572 ("the '572 patent") (PTX External link to document
2011-09-09 162 271” “532 patent” / “Chang patent” TABLE OF ABBREVIATIONS Refers collectively to U.S. Patent Nos. 5 ,…11 Page 5 of 17 Page|D #: 10853 “Amin patents” ‘°Ashley patents” “D.I. 892-X” “D.I. 184-X” “Galderma…Mylan prevailed on four of the five patents-in-suit and the one patent upon Which Galderma "Ci »-s…prevailed on four of the five patents-in~suit and the fact that the Chang patent did not issue until Well…infringe the Ashley or Amin patents, yet Galderma was able to use the Ashley patents and this litigation to External link to document
2011-09-09 163 of U.S. Patent Nos. 7,211,267 (the “‘267 patent”),` 7,232,572 (the “‘572 patent”), 5,789,395 (the “‘395…‘395 patent”), and 5,919,775 (the “‘775 patent”). l also understand that these patents Were issued by …claims of the aforementioned patents, including the ’267 and ’572 patents on Which the Court based the…injunction 1 understand that U.S. Patent No. 7,749,532 (the “Chang patent”) issued on July 6, 2010, after…the Chang patent, Which Was found to be valid. With respect to permanent injunctions in patent cases, l External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
Express Scripts
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.